Published online before print September 27, 2004, doi: 10.1161/01.CIR.0000143174.41810.10
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:1953-1959.)
© 2004 American Heart Association, Inc.
Genetics |
Genetically Determined Resistance to Collagenase Action Augments Interstitial Collagen Accumulation in Atherosclerotic Plaques
From the Donald W. Reynolds Cardiovascular Clinical Research Center, Department of Medicine (Y.F., J.D., Y.S., M.T.C., C.C.H., P.R.L., N.V.), and the Department of Pathology (E.R.-A., F.J.S.), Brigham and Women’s Hospital, Harvard Medical School, and the Department of Medicine (S.M.K.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Masanori Aikawa, MD, PhD, Brigham and Women’s Hospital, Harvard Medical School, 77 Ave Louis Pasteur, NRB741, Boston, MA 02115. E-mail maikawa{at}rics.bwh.harvard.edu
Received November 6, 2003; de novo received May 24, 2004; accepted May 26, 2004.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— We hypothesized that collagenolytic activity produced by activated macrophages contributes to collagen loss and the subsequent instability of atheromatous lesions, a common trigger of acute coronary syndromes. However, no direct in vivo evidence links collagenases with the regulation of collagen content in atherosclerotic plaques.
Methods and Results— To test the hypothesis that collagenases influence the structure of atheromata, we examined collagen accumulation in atherosclerotic lesions of apolipoprotein E-deficient mice (apoE–/–) that express collagenase-resistant collagen-I (ColR/R/apoE–/–, n=12) or wild-type collagen-expressing mice (Col+/+/apoE–/–, n=12). Aortic atheromata of both groups had similar sizes and numbers of macrophages, a major source of collagenases. However, aortic intimas from ColR/R/apoE–/– mice contained fewer smooth muscle cells, a source of collagen, probably because of decreased migration or proliferation or increased cell death. Despite reduced numbers of smooth muscle cells, atheromata of ColR/R/apoE–/– mice contained significantly more intimal collagen than did those of Col+/+/apoE–/– mice.
Conclusion— These results establish that collagenase action regulates plaque collagen turnover and smooth muscle cell accumulation.
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Degradation of extracellular matrix by matrix metalloproteinases (MMPs) may play various critical roles in the progression and complications of atherosclerotic plaques. Atherosclerotic lesions prone to the onset of acute coronary syndromes usually contain abundant macrophages underlying a thin and collagen-poor fibrous cap.1,2 Extracellular matrix macromolecules, notably fibrillar interstitial collagens, confer tensile strength on the plaque’s fibrous cap.3 Indirect evidence suggests that macrophage expression of MMPs in atheromata weakens the plaque’s protective fibrous cap and promotes disruption and subsequent thrombosis.4–12 In particular, collagenases of the MMP family (MMP-1/collagenase-1, MMP-8/collagenase-2, and MMP-13/collagenase-3) break down fibrillar collagens.13 However, no direct in vivo evidence has determined that MMP-family collagenases regulate the interstitial collagen content of atheromata. Indeed, plaques also contain non-MMP collagenases, including cathepsin K, a potent cysteine proteinase that can degrade interstitial collagen.14 The relative contributions of MMP and non-MMP collagenases to collagen metabolism in the plaque remain unknown.
Smooth muscle cells (SMCs) participate in the progression of atherosclerosis. Migration from the tunica media and the balance between proliferation and cell death determine SMC content in the intima. Although some studies suggest that MMPs may mediate SMC migration through the collagenous matrix of plaques,15–19 the in vivo role of collagenases in this context remains unproven.
Interstitial collagenases of the MMP family initiate degradation of type I collagen by cleavage at a single highly conserved site between Gly775 and Ile776 of the 
1(I) chain. The present study used mice with a targeted mutation in both alleles of Col1a1 (Col1a1tml Jae or ColR/R) that yields amino acid substitutions around the collagenase cleavage site in the 1(I) chains that render collagen completely resistant to attack by MMP collagenases.20–22 We crossed ColR/R mice and apoE-deficient strain (apoE–/–) mice to test the specific biological hypothesis in vivo that MMP collagenases regulate collagen accumulation in intimal plaques, an aspect of plaque structure critical to the progression and complications of atherosclerosis.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Animal Preparation
ColR/R mice (C57BL/6x129) were backcrossed 7 generations into C57BL/6 mice and then crossed into apoE-deficient mice (apoE–/–, C57BL/6) to render ColR/R mice atherosclerosis susceptible. The procedure yielded ColR/R/apoE–/– and Col+/+/apoE–/– mice, as demonstrated by polymerase chain reaction (PCR)–based genotyping. ColR/R/apoE–/– (n=12) and Col+/+/apoE–/– (n=12) littermates consumed an atherogenic diet (semipurified chow containing 1.25% cholesterol and 0% cholate) for 10 weeks. All experiments conformed to a protocol approved by the Standing Committee on Animals of Harvard Medical School.
Tissue Preparation
Mice were anesthetized and perfused with phosphate-buffered saline (pH 7.4) through a 23-gauge cannula in the left ventricle. The hearts were subsequently immersed in saline for 1 hour and then with 4% phosphate-buffered paraformaldehyde (pH 7.4) for an additional 48 hours. Hearts dissected in the region of the proximal aorta23 were embedded in paraffin, and 5-µm serial sections were cut. Histological analyses used sections 
50 µm above the beginning of the aortic sinuses. The aortas for RNA extraction were harvested, and the adventitia was removed while being viewed under a microscope.
Histological Assays
Immunohistochemistry studies included use of a mouse monoclonal antibody against human -SM actin (Dako) with a kit for mouse antibodies on mouse tissue (InnoGenex), rat monoclonal antibody against mouse macrophages (Mac3, PharMingen), rabbit polyclonal antibody against MMP-13/collagenase-3 (a gift from Dr C. William Wu, University of Tennessee, Memphis),24 rabbit polyclonal anti-mouse cathepsin K (Santa Cruz), or nonimmune rabbit IgG as a negative control. The peptide at the linker region between propeptide and catalytic domains (PNPKHPKTPEK) was chosen from the amino acid sequence of mouse MMP-13/collagenase-3 to raise the specific antibody. The sequence of this peptide significantly differs from all other proteins including MMPs (E values >4.7, NCBI Blast). A mouse proliferating cell nuclear antigen staining kit (Zymed) and ApopTaq Plus (Intergen) were used to determine cell proliferation and death. We analyzed picrosirius red staining under polarized light to detect interstitial collagen.8
Peritoneal Macrophage Culture
Four days after an intraperitoneal injection of 4.1% thioglycollate, primary peritoneal macrophages were harvested from mice and cultured with Dulbecco’s modified Eagle’s medium (DMEM). After incubation with DMEM containing 10% fetal calf serum for 24 hours, the culture media of adherent cells were changed to fresh DMEM with or without 10% fetal calf serum and incubated for 72 hours.
RT-PCR and Western Blotting
Total RNA was extracted from peritoneal macrophages (n=3 per group) and mouse aortas (pooled, n=3 per group) and reverse-transcribed (RT). Real-time PCR used SYBR Green PCR master mix and the ABI PRISM 5600 sequence detection system (Applied Biosystems). Oligonucleotide primer pairs used to recognize mouse mRNAs included MMP-8, 5'-CAA-CCT-ATT-TCT-CGT-GGC-TG -3'and 5'-TGC-AGG-TCA-TAG-CCA-CTT-AG-3'; MMP13, 5'-TCC-CTT-GAT-GCC-ATT-ACC-AGT-C-3' and 5'-AAA-AAG-AGC-TCA-GCC-TCA-ACC-TG; 1 procollagen-I, 5'-AAG-GTG-CTG-ATG-GTT-CTC-C-3' and 5'-TCT-TTC-TCC-TCT-CTG-ACC-G-3'; and ß-actin (internal control), 5'-CAC-ACT-GTG-CCC-ATC-TAC-GA-3' and 5'-GTT-TCA-TGG-ATG-CCA-CAG-GA-3'.
Cell lysates for Western blotting from peritoneal macrophages were obtained with use of a buffer containing 125 mmol/L Tris-HCl, pH 6.8, 20% glycerol, 4.6% sodium dodecyl sulfate, and 10% mercaptoethanol. Western blotting used the same rabbit polyclonal antibody against MMP-13/collagenase-3 as for immunohistochemistry.
Preparation of Mouse SMCs and Migration Assay
Isolation of mouse SMCs for migration assay was adapted from the method of Gunther et al.25 Aortas from C57BL/6 mice were digested with 1 mg/mL collagenase type II (Worthington). After the endothelium and adventitia were carefully removed, aortas were chopped and digested with type I collagenase (1 mg/mL, Worthington) and elastase III (0.125 mg/mL, Sigma). Cells were then cultured and passaged. SMC migration was evaluated with dual-chamber 24-well plates with 8-µm polycarbonate membranes (Costar) coated with 10 µg/mL collagen solution extracted from Col+/+/apoE–/– or ColR/R/apoE–/– mice.20 The lower chambers were filled with DMEM with or without 1 ng/mL platelet-derived growth factor-BB, and 40 000 cells were added to the upper chambers. After incubation for 4 hours, cells that had migrated to the lower surface of the membrane were fixed, stained with use of the Protocol HEMA3 staining kit (Fisher), and counted in 4 x100 fields per well.
Quantitative Analysis and Statistics
Quantitative analysis of histological assays used a digital imaging system as previously described.8,12 In brief, images were transferred into an ImagePro image analysis system (Media Cybernetics). A color threshold mask for immunostaining was defined by sampling the red color, and the same threshold was applied to all specimens. The percentage of the total area with positive color for each section was recorded. For picrosirius red staining, a negative background (black) was chosen for thresholding, and the positive area was calculated by subtraction. Two investigators performed these analyses independently and without knowledge of genotype. Interobserver correlation was excellent (r=0.98). Differences between the 2 groups or among multiple groups were determined by the Mann-Whitney U test or 1-way ANOVA followed by Fisher test, respectively.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Plasma Lipids
On the atherogenic diet, plasma total cholesterol levels in ColR/R/apoE–/– mice (n=12, 1113±118 mg/dL) and Col+/+/apoE–/– mice (atherosclerotic wild-type, n=12, 1279±202 mg/dL) did not differ.
Alterations in Endogenous Collagenase and Procollagen Expression
Previous animal studies demonstrated disparate results with regard to the role of MMPs on atheroma burden.26–30 In aortic atheromata from cholesterol-fed ColR/R/apoE–/– and Col+/+/apoE–/– mice, lesion areas were similar (Figures 1A–1C). Collagenase resistance also did not change macrophage areas and areas where cells expressed MMP-13/collagenase-3 (Figures 1A–1C). We furthermore observed no significant difference in areas immunopositive for cathepsin K, a major non-MMP collagenase (data not shown, P=0.78) We then evaluated possible alterations in endogenous collagenase expression in response to collagenase resistance. Levels of MMP-8/collagenase-2 and MMP-13/collagenase-3 mRNAs by real-time RT-PCR on thioglycollate-stimulated peritoneal macrophages were similar in both groups of mice (Figure 2A). However, macrophage expression of MMP-13/collagenase-3 appeared to be more abundant than that of MMP-8/collagenase-2 (Figure 2A). Protein expression of latent and active MMP-13/collagenase-3 in both groups as evaluated from Western blots was similar (pro-MMP-13, 57 kDa; active MMP-13, 45 kDa with subsequent autolytic cleavage to a 20-kDa form; Figure 2B). Absorption by the same peptide that was used to raise the antibody (PNPKHPKTPEK) diminished these bands. These results indicate that collagenase resistance did not affect the capacity of macrophages to express collagenases.
|
|
We further examined levels of mRNAs encoding collagenases in the aortas. Real-time RT-PCR showed an increase in MMP-13/collagenase-3 mRNA levels and a decrease in 1 type I procollagen mRNA levels in aortas from ColR/R/apoE–/– mice compared with those from Col+/+/apoE–/– mice (n=3 each, pooled), whereas MMP-8/collagenase-2 mRNA levels did not change substantially (Figure 2C). Levels of mRNA encoding Mcol-A, a possible mouse orthologue of MMP-1/collagenase-1,31 were below the limits of detectability in these assays (data not shown).
Collagenase-Resistant Mice Have Fewer Intimal SMCs
SMCs synthesize most arterial collagen. Atheromata of ColR/R/apoE–/– mice contained significantly fewer SMCs than did those of Col+/+/apoE–/– mice (Figures 3A and 3B). Proliferating cell nuclear antigen and terminal dUTP nick end-labeling staining indicated decreased proliferation and increased death of intimal SMCs in ColR/R/apoE–/– mice compared with Col+/+/apoE–/– mice (Figure 4A and 4B). SMCs enter the intima by migration from the tunica media or from the blood. To determine whether collagenase resistance influences the ability of SMCs to migrate, we performed in vitro migration assay with dual-chamber plates. Because the current study used compound-mutant mice for the substrate, not for enzymes, we measured the traversal of wild-type SMCs from C57BL6 mice through polycarbonate filters coated with a layer of interstitial collagen extracted from Col+/+/apoE–/– or ColR/R/apoE–/– mice. This assay showed a decreased ability of SMCs to migrate through collagenase-resistant collagen compared with wild-type collagen (Figure 4C and 4D).
|
|
Collagenase Resistance Increases Collagen Content in the Intima of Aortic Atheromata of ApoE–/– Mice
The tunica intima of aortic atheromata of Col+/+/apoE–/– mice exhibited patchy accumulation of interstitial collagen, as determined by picrosirius red staining analyzed by polarization (Figure 5A). However, the aortic intimas of ColR/R/apoE–/– mice contained substantially more interstitial collagen than did those of Col+/+/apoE–/– mice. Quantitative analyses of picrosirius red birefringence in the intima indicated that collagenase resistance significantly increased collagen content in terms of absolute area, percentage area, and area divided by SMC number, a major source of collagen production (Figure 5B).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
We previously advanced the hypothesis that a highly regulated balance of synthesis and degradation determines collagen content in the fibrous cap of atherosclerotic plaques.1,2 In turn, collagen levels critically influence the integrity of the plaque’s cap, a structure whose biomechanical failure may cause most myocardial infarctions. Earlier indirect evidence suggested that collagenases of the MMP family can regulate collagen content in the plaque.5–12 We initially demonstrated overexpression of the prototypical interstitial collagenase MMP-1 in human atheromata5 and later showed colocalization of MMP-1/collagenase-1 and MMP-13/collagenase-3 with degraded collagen in these lesions as detected by an antibody specific for the collagenase cleavage site of collagen.9 Recently, our group showed that human atheromata contain a third interstitial collagenase, MMP-8/collagenase-2,11 also present in mouse atheromata, as shown here (Figure 2C). Shah et al32 reported that conditioned media of cultured macrophages could digest collagen obtained from the human fibrous cap and that addition of a nonselective MMP inhibitor blocked this process in vitro. Moreover, we demonstrated that lipid lowering in hypercholesterolemic rabbits decreased collagenase expression and, in parallel, increased collagen accumulation in atheromata, suggesting a potential role for collagenases in collagen metabolism and stability in atheromata.8,33 Lemaitre et al30 reported that macrophage-selective overexpression of human MMP-1/collagenase-1 in apoE-deficient mice decreased lesion size, although they did not provide quantitative analysis of collagen accumulation in the lesions. Our present study indicates that impaired collagen degradation due to introduction of collagenase resistance increased the content of this extracellular matrix component in the atherosclerotic intima, despite reduced numbers of SMCs and procollagen-I expression. These results thus demonstrate directly in vivo a critical role for collagenolysis in determining the collagen turnover of plaques. Moreover, they suggest that regulation of the levels of degradation (by MMP collagenases) outweighs the contribution of synthesis (by SMCs) to collagen accumulation in the atherosclerotic plaque.
The reduced SMC accumulation in atheromata was an unexpected phenotype of these compound-mutant mice. The mechanistic studies presented here suggest that a combination of decreased migration, decreased proliferation, and/or increased cell death contribute to the relative paucity of SMCs in plaques of ColR/R/apoE–/– mice. These results agree with previous studies that showed that native, undegraded interstitial collagen can limit SMC proliferation and that SMC migration in vitro depends in large part on MMP action.15–19,34 Our finding of increased apoptosis in SMCs resembles the increased apoptosis observed in osteoblasts and osteocytes in ColR/R mice.22 ColR/R mice also display increased collagen accumulation in the wounded dermis and in experimental hepatic cirrhosis.35,36
The present study supports an in vivo role for collagen breakdown by MMP-family collagenases in the regulation of the collagenous skeleton of atheromata, an important determinant of the plaque’s propensity to provoke an acute thrombotic event in patients. Regulation of collagen biology also has profound effects on SMC functions, as shown here. Our findings underscore the importance of the regulation of collagen metabolism in the pathophysiology of the atherosclerotic plaque.
|
Acknowledgments |
|---|
This work was supported in part by National Institutes of Health grants SCOR HL-56985 (to Drs Libby and Aikawa), P01 HL-48743 (to Dr Libby), and AR-44185 (to Dr Krane) and by Banyu/Merck and Uehara Fellowship Awards (to Dr Fukumoto). We acknowledge Dr C. William Wu, University of Tennessee, for the MMP-13 antibody and his valuable insights on this work. We also thank Karen E. Williams for her editorial expertise.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995; 91: 2844–2850.
2. Aikawa M, Libby P. The vulnerable atherosclerotic plaque; pathogenesis and therapeutic approach. Cardiovasc Pathol. 2004; 13: 125–138.[Medline] [Order article via Infotrieve]
3. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 1997; 17: 1859–1867.
4. Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991; 88: 8154–8158.
5. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994; 94: 2493–503.[Medline] [Order article via Infotrieve]
6. Nikkari ST, O’Brien KD, Ferguson M, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995; 92: 1393–1398.
7. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997; 17: 439–444.[CrossRef][Medline] [Order article via Infotrieve]
8. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998; 97: 2433–2444.
9. Sukhova G, Schoenbeck U, Rabkin E, et al. Evidence of increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999; 99: 2503–2509.
10. Aikawa M, Rabkin E, Sugiyama S, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001; 103: 276–283.
11. Herman MP, Sukhova GK, Libby P, et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation. 2001; 104: 1899–1904.
12. Fukumoto Y, Libby P, Rabkin E, et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation. 2001; 103: 993–999.
13. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 2002; 3: 207–214.[CrossRef][Medline] [Order article via Infotrieve]
14. Sukhova GK, Shi GP, Simon DI, et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest. 1998; 102: 576–583.[Medline] [Order article via Infotrieve]
15. Kenagy RD, Clowes AW. A possible role for MMP-2 and MMP-9 in the migration of primate arterial smooth muscle cells through native matrix. Ann N Y Acad Sci. 1994; 732: 462–465.[Medline] [Order article via Infotrieve]
16. Bendeck MP, Irvin C, Reidy MA. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res. 1996; 78: 38–43.
17. Prescott MF, Sawyer WK, Von Linden-Reed J, et al. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci. 1999; 878: 179–190.[CrossRef][Medline] [Order article via Infotrieve]
18. Cowan KN, Jones PL, Rabinovitch M. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res. 1999; 84: 1223–1233.
19. Kuzuya M, Kanda S, Sasaki T, et al. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation. 2003; 108: 1375–1381.
20. Liu X, Wu H, Byrne M, et al. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol. 1995; 130: 227–237.
21. Zhao W, Byrne MH, Boyce BF, et al. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest. 1999; 103: 517–524.[Medline] [Order article via Infotrieve]
22. Zhao W, Byrne MH, Wang Y, et al. Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest. 2000; 106: 941–949.[Medline] [Order article via Infotrieve]
23. Paigen B, Morrow A, Holmes P, et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987; 68: 231–240.[CrossRef][Medline] [Order article via Infotrieve]
24. Wu CW, Tchetina EV, Mwale F, et al. Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization. J Bone Miner Res. 2002; 17: 639–651.[CrossRef][Medline] [Order article via Infotrieve]
25. Gunther S, Alexander RW, Atkinson WJ, et al. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol. 1982; 92: 289–298.
26. Rouis M, Adamy C, Duverger N, et al. Adenovirus-mediated overexpression of issue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation. 1999; 100: 533–540.
27. Dollery CM, Humphries SE, McClelland A, et al. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation. 1999; 99: 3199–3205.
28. Silence J, Collen D, Lijnen HR. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res. 2002; 90: 897–903.
29. Silence J, Lupu F, Collen D, et al. Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol. 2001; 21: 1440–1445.
30. Lemaitre V, O’Byrne TK, Borczuk AC, et al. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest. 2001; 107: 1227–1234.[Medline] [Order article via Infotrieve]
31. Balbin M, Fueyo A, Knauper V, et al. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem. 2001; 276: 10253–10262.
32. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995; 92: 1565–1569.[Medline] [Order article via Infotrieve]
33. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002; 8: 1257–1262.[CrossRef][Medline] [Order article via Infotrieve]
34. Koyama H, Raines EW, Bornfeldt KE, et al. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996; 87: 1069–1078.[CrossRef][Medline] [Order article via Infotrieve]
35. Issa R, Zhou X, Trim N, et al. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J. 2003; 17: 47–49.
36. Beare AH, O’Kane S, Krane SM, et al. Severely impaired wound healing in the collagenase-resistant mouse. J Invest Dermatol. 2003; 120: 153–163.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  J.-o Deguchi, H. Yamazaki, E. Aikawa, and M. Aikawa Chronic Hypoxia Activates the Akt and {beta}-Catenin Pathways in Human Macrophages Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1664 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Libby Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S352 - S357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Adiguzel, P. J Ahmad, C. Franco, and M. P Bendeck Collagens in the progression and complications of atherosclerosis Vascular Medicine, February 1, 2009; 14(1): 73 - 89. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Franco, G. Hou, P. J. Ahmad, E. Y.K. Fu, L. Koh, W. F. Vogel, and M. P. Bendeck Discoidin Domain Receptor 1 (Ddr1) Deletion Decreases Atherosclerosis by Accelerating Matrix Accumulation and Reducing Inflammation in Low-Density Lipoprotein Receptor-Deficient Mice Circ. Res., May 23, 2008; 102(10): 1202 - 1211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Schneider, G. K. Sukhova, M. Aikawa, J. Canner, N. Gerdes, S.-M. T. Tang, G.-P. Shi, S. S. Apte, and P. Libby Matrix Metalloproteinase-14 Deficiency in Bone Marrow-Derived Cells Promotes Collagen Accumulation in Mouse Atherosclerotic Plaques Circulation, February 19, 2008; 117(7): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fung, S.-M. T. Tang, J. P. Canner, K. Morishige, J. F. Arboleda-Velasquez, A. A. Cardoso, N. Carlesso, J. C. Aster, and M. Aikawa Delta-Like 4 Induces Notch Signaling in Macrophages: Implications for Inflammation Circulation, June 12, 2007; 115(23): 2948 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Libby Perplexity of Plaque Proteinases Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2181 - 2182. [Full Text] [PDF]
|
|
|
|
|
|
J.-o Deguchi, M. Aikawa, C.-H. Tung, E. Aikawa, D.-E. Kim, V. Ntziachristos, R. Weissleder, and P. Libby Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo Circulation, July 4, 2006; 114(1): 55 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Dollery and P. Libby Atherosclerosis and proteinase activation Cardiovasc Res, February 15, 2006; 69(3): 625 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pearce, D.-A. Tregouet, A. Samnegard, A. R. Morgan, C. Cox, A. Hamsten, P. Eriksson, and S. Ye Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction Circ. Res., November 11, 2005; 97(10): 1070 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-O Deguchi, E. Aikawa, P. Libby, J. R. Vachon, M. Inada, S. M. Krane, P. Whittaker, and M. Aikawa Matrix Metalloproteinase-13/Collagenase-3 Deletion Promotes Collagen Accumulation and Organization in Mouse Atherosclerotic Plaques Circulation, October 25, 2005; 112(17): 2708 - 2715. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||